Change in Oxidative Stress Markers – Metabolic Syndrome Clinical Study

• Overview (study design, subjects background, etc.) – metabolic syndrome clinical study

Therapeutic intervention for Group C: standard of care
Therapeutic intervention for Group R: standard of care and RE therapy

After eight weeks of therapy, the ROS and MDA values for Group R were statistically significantly lower than those for Group C, while the SOD value for Group R was statistically significantly higher than that for Group C.

The ROS is a major cause of oxidative stress, the SOD is an antioxidant enzyme, while the MDA is a degradation product of lipid peroxidation substances produced as a result of lipid oxidation.

From these, adding RE therapy to the standard of care was inferred to be effective in comprehensively improving oxidative stress in patients with metabolic syndrome.